Biomarin Pharmaceutical - Registered Shares Overview
Biomarin Pharmaceutical - Registered Shares Target Price
See Biomarin Pharmaceutical - Registered Shares's analyst price targets ($91) vs the current share price.
Get informed when a big investor buys or sells
+ FollowShare Price
$66.99
Average Target Price
$91.23
36.2% upside
36.2% upside13 analysts in the last 4 months
High: $124 | Low: $50
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-08-10 | Canaccord GenuityWhitney Ijem | $114 | 70.2% upside |  |
| 2026-08-07 | Raymond James | $105 | 56.7% upside | |
| 2026-08-07 | Morgan Stanley | $124 | 85.1% upside | |
| 2026-08-07 | Stifel Nicolaus | $70 | 4.5% upside | |
| 2026-08-07 | OppenheimerLeland Gershell | $97 | 44.8% upside | |
| 2026-07-07 | RBC CapitalLuca Issi | $62 |  7.4% downside | |
| 2026-05-22 | Canaccord Genuity | $111 | 65.7% upside | |
| 2026-05-18 | Leerink Partners | $62 | 7.4% downside | |
| 2026-05-18 | H.C. Wainwright | $50 | 25.4% downside | |
| 2026-05-11 | Goldman Sachs | $69 | 3% upside | |
| 2026-05-05 | Evercore ISI | $120 | 79.1% upside | |
| 2026-05-05 | Tudor PickeringWilliam Pickering | $82 | 22.4% upside | |
| 2026-04-27 | Morgan StanleySean Laaman | $120 | 79.1% upside | |
| 2026-03-12 | JefferiesAkash Tewari | $103 | 53.8% upside | |
| 2026-03-03 | BarclaysEliana Merle | $105 | 56.7% upside | |
| 2026-03-02 | Loop Capital MarketsIlya Zubkov | $105 | 56.7% upside | |
| 2026-02-26 | Canaccord GenuityWhitney Ijem | $104 | 55.2% upside | |
| 2026-02-24 | Oppenheimer | $95 | 41.8% upside | |
| 2026-02-24 | Stifel NicolausPaul Matteis | $68 | 1.5% upside | |
| 2026-02-18 | Wells Fargo | $75 | 12% upside | |
| 2026-02-06 | Piper Sandler | $84 | 25.4% upside | |
| 2026-01-20 | Canaccord Genuity | $98 | 46.3% upside | |
| 2025-12-23 | Truist FinancialJoon Lee | $100 | 49.3% upside | |
| 2025-12-22 | H.C. Wainwright | $60 | 10.4% downside | |
| 2025-12-03 | Leerink Partners | $60 | 10.4% downside | |
| 2025-11-03 | Tudor PickeringWilliam Pickering | $88 | 31.4% upside | |
| 2025-11-03 | Bernstein | $88 | 31.4% upside | |
| 2025-10-28 | RBC CapitalLuca Issi | $66 | 1.5% downside | |
| 2025-10-28 | Stifel Nicolaus | $73 | 9% upside | |
| 2025-10-28 | Truist FinancialJoon Lee | $80 | 19.4% upside | |
| 2025-10-28 | Morgan StanleySean Laaman | $98 | 46.3% upside | |
| 2025-10-28 | H.C. Wainwright | $55 | 17.9% downside | |
| 2025-10-28 | Wells FargoMohit Bansal | $70 | 4.5% upside | |
| 2025-10-28 | Barclays | $80 | 19.4% upside | |
| 2025-08-05 | UBS | $114 | 70.2% upside | |
| 2025-07-15 | Wolfe ResearchAkash Tewari | $95 | 41.8% upside | |
| 2024-10-30 | Cantor FitzgeraldOlivia Brayer | $90 | 34.3% upside | |
| 2024-10-30 | Robert W. BairdJack Allen | $65 | 3% downside | |
| 2024-10-30 | CitigroupDavid Lebowitz | $81 | 20.9% upside | |
| 2024-10-10 | Raymond JamesDanielle Brill | $79 | 17.9% upside | |
| 2024-10-04 | BarclaysGena Wang | $86 | 28.4% upside | |
| 2024-09-18 | CitigroupDavid Lebowitz | $93 | 38.8% upside | |
| 2024-09-17 | ScotiabankGeorge Farmer | $78 | 16.4% upside | |
| 2024-09-17 | Truist FinancialJoon Lee | $90 | 34.3% upside | |
| 2024-09-17 | BernsteinWilliam Pickering | $90 | 34.3% upside | |
| 2024-09-17 | BMO CapitalKostas Biliouris | $115 | 71.7% upside | |
| 2024-09-16 | BarclaysGena Wang | $110 | 64.2% upside | |
| 2024-09-05 | Raymond JamesChristopher Raymond | $122 | 82.1% upside | |
| 2024-09-05 | ScotiabankGeorge Farmer | $95 | 41.8% upside | |
| 2024-08-27 | Raymond JamesChristopher Raymond | $107 | 59.7% upside | |